Join BIOCYTOGEN at BioFit 2024

We’re thrilled to announce our participation as an exhibitor at BioFIT 2024! From December 3rd to 4th in Lille, France, this prestigious event will bring together leading experts and innovators in life sciences to exchange insights, spark collaboration, and drive new advancements. Join us in exploring the future of the field!

What is BioFit 2024?

BioFIT is Europe’s leading partnering event for life sciences, gathering over 1,000 international players from 35+ countries. Attendees include major pharma companies, biotech firms of all sizes, diagnostic companies, investors from pre-seed to Series A, and professionals from tech transfer, academia, and research institutions. This event serves as a premier marketplace for academia-industry collaborations, technology transfer, and early-stage innovation deals, as well as a key venue for investment rounds in the life sciences sector.

Event Overview  

Date: December 3rd 9:00 am – 4th 04:30 pm

Venue: Lille Grand Palais, 1, Boulevard des Cités Unies, 59777 Lille, FRANCE

Event Schedule

The BioFit in Lille, France will showcase a diverse array of speakers and topics. For a comprehensive look at the daily schedule, including session times and detailed information on each presentation, please refer to the BioFit 2024 agenda.

About BIOCYTOGEN

Biocytogen is a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies. Founded on gene editing technology, Biocytogen leverages genetically engineered proprietary RenMice® platforms for fully human monoclonal antibody discovery, and has established a sub-brand, RenBiologics™, to explore global partnerships for an off-the-shelf library of >400,000 fully human antibody sequences against approximately 1000 targets for worldwide collaboration. Biocytogen pioneered the generation of drug target knock-in humanized models for preclinical research, and currently provides a few thousand off-the-shelf animal and cell models under the company’s sub-brand, BioMice™, along with preclinical pharmacology and gene-editing services for clients worldwide. Headquartered in Beijing, Biocytogen has branches in China (Haimen Jiangsu, Shanghai), USA(Boston, San Francisco), and Germany (Heidelberg).

We look forward to seeing you at the BioFit in Lille, France!